CMIIUCM Life Sciences II Inc.

NAS · US · Financial Services · Shell Companies

10.95USD0.00%Mkt Cap: —P/E: —4d ago

Columbus Circle Capital Corp II does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with o…

Industry Peers

Shell Companies

Drugs Made In America Acquisition II Corp. Ordinary Shares

$645.92MUSDP/E 35.0

BCSS

Bain Capital GSS Investment Corp. Class A Ordinary Shares

$600.35MUSD

EVAC

EQV Ventures Acquisition Corp. II

$600.26MUSDP/E 14.7

CXII

Churchill Capital Corp XII Class A Ordinary Shares

$595.50MUSD

CEPF

Cantor Equity Partners IV Inc. Class A Ordinary Shares

$590.93MUSDP/E 27.9

AEXA

American Exceptionalism Acquisition Corp. A

$577.70MUSD

DBCA

D. Boral Acquisition I Corp. Class A Ordinary Shares

$555.37MUSD

VACH

Voyager Acquisition Corp Class A Ordinary Shares

$541.25MUSDP/E 81.5

GCGR

General Catalyst Global Resilience Merger Corp. Class A Ordinary Shares

$514.21MUSD

NWAX

New America Acquisition I Corp. Class A Common Stock

$506.96MUSD

MEVO

M Evo Global Acquisition Corp II Class A Ordinary Shares

$499.00MUSD

KRSP

Rice Acquisition Corporation 3

$487.63MUSD

RFAI

RF Acquisition Corp II Ordinary Shares

$483.94MUSDP/E 483.3

GIW

GigCapital8 Corp. Class A Ordinary Shares

$480.90MUSD

GTEN

Gores Holdings X Inc. Class A ordinary shares

$478.70MUSDP/E 6.9

ANSC

Agriculture & Natural Solutions Acquisition Corporation Class A Ordinary Shares

$476.13MUSDP/E 52.1

CRAN

Crane Harbor Acquisition Corp. II Class A Ordinary Shares

$475.57MUSD

APXT

APEX TECHNOLOGY ACQUISITION CORP

$464.43MUSD

IEAG

Infinite Eagle Acquisition Corp. Class A Ordinary Shares

$444.99MUSD

Key Statistics

Company

Market Cap—

Enterprise Value341.89M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-61.42K $

Revenue/Share—

Last Price10.95 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees—

CountryUS

SectorFinancial Services

IndustryShell Companies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B239.78

EPS (TTM)—

EPS (Forward)—

52W Range

9.940100% of range10.95

52W High10.95 USD

52W Low9.940 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE—

ROA—

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF0 $

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt-1.19M $

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio0.03

Quick Ratio—

Book Value/Sh0.0450 USD

Cash/Share0.0380 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float21.60M

Insiders1.12%

Institutions4.59%

Short Interest

Short Ratio6.3d

Shares Short100

Short (prev mo.)100

Technical

SMA 5010.78 (+1.6%)

SMA 20010.30 (+6.3%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)0

Avg Vol (10d)0

Technical Indicators

RSI (14)87.2

MACD0.0376

MACD Signal0.0532

MACD Hist.-0.0156

BB Upper10.95 USD

BB Middle10.95 USD

BB Lower10.95 USD

BB Width0.00%

ATR (14)0.0046 USD

Vol Ratio (20d)—